Arjun JJ Desai - 10 Aug 2023 Form 3 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role: Director
Signature: /s/ Sean Murphy, Attorney-in-Fact for Arjun Desai
Issuer symbol: TLSI
Transactions as of: 10 Aug 2023
Net transactions value: $0
Form type: 3
Filing time: 14 Aug 2023, 17:37:17 UTC
Next filing: 19 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TLSI	Common Stock						203,127	10 Aug 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TLSI	Redeemable Warrant							10 Aug 2023	Common Stock	246,667		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock received as a pro rata distribution for no consideration from MedTech Acquisition Sponsor LLC ("Sponsor") in accordance with the terms of the Sponsor's limited liability company agreement.
F2	The redeemable warrants expire on August 9, 2028, or earlier upon redemption or liquidation.
F3	Represents warrants received as a pro rata distribution for no consideration from the Sponsor in accordance with the terms of the Sponsor's limited liability company agreement.